SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 108.190.0%10:33 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: opalapril who wrote (1463)5/19/2000 1:35:00 PM
From: Lighthouse  Read Replies (1) of 3202
 
I am no expert on this issue, but to the best of my understanding: Bowie issued a bond to investors with a face amount of $50 or $55 million. Bowie received the proceeds of the offering. The bonds are backed by the royalty revenue of his recordings. Bowie gets cash now, buyers of the bond get an interest rate and the collateral of the bond is the future royalties on Bowie's songs.

My sense is Whitfield was floating a "trial balloon" to see the market's reaction. Whitfield categorized the royalty stream as non strategic to INCY's future. In one sense this is true on another sense I am unsure.

I have asked Peter Suzman on the "Biotech Valuation" thread for his opinion as to this potential spin off. I am awaiting his response.

Hope this helps,

Cheers,
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext